6505--lenalidomide
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C25226Q0112
- Agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12, specifically the Jesse Brown VA Medical Center's Pharmacy Service Department, is soliciting bids for the procurement of Lenalidomide/Revlimid medication in capsule form across multiple dosages ranging from 2.5mg to 25mg. Vendors must be certified with the Lenalidomide REMS program and capable of managing the specific prescription ordering, patient counseling, medication shipping, and delivery confirmation processes outlined in the solicitation. The contract will be awarded on a lowest price technically acceptable basis over a 12-month performance period. The response deadline has been extended to December 3, 2025, at 3:00 p.m. CST, as indicated by the recent amendment to the solicitation (36C25226Q0112). All other terms and conditions of the original solicitation remain in effect following this deadline extension.
This procurement includes no set-aside designations and carries an estimated total quantity of 3,952 capsules plus 1,008 new starts for direct dispensing to veterans. Shipping fees must not exceed $250, and invoicing will be conducted electronically through the Tungsten Network. The contract will be administered by the VA Great Lakes Acquisition Center in Milwaukee, Wisconsin, with Contracting Officer Jim Hedman overseeing the procurement. The selected vendor must meet all requirements related to the Lenalidomide REMS program compliance and possess the capability to fulfill the medication dispensing requirements directly to the Jesse Brown VA Medical Center's patient population. Performance will take place at the Jesse Brown VA Medical Center, with all pharmaceutical preparation activities conducted in compliance with federal and VA pharmacy regulations.
Notice text
2 versions
Update #2 · Latest ·
This amendment hereby changes the date for which responses are due from 12/1/2025 at 3:00 p.m. CST to 12/3/2025 at 3:00 p.m. CST. All other terms and conditions remain in effect.
Update #1 ·
Lenalidomide
Files
| File | Type | Posted |
|---|---|---|
| 36C25226Q0112 0001.docx | DOCX document | |
| 36C25226Q0112.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--LENALIDOMIDE Jesse Brown VA Medical Center | Award Notice | |
| This notice | Solicitation | |
| 6505--lenalidomide | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity